Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
In order to develop innovative biomarkers for the diagnosis of two ocular surface pathologies, Dry Syndrome (DS) and Limbic Stem Cell Deficiency (LSCD), human cells from the ocular surface will be collected in order to test these biomarkers ex vivo.
Full description
To collect them, cytological fingerprints of the ocular surface are made using filter paper applied to the surface using a commercially available EC (European Conformity)-marked medical device, called EYEPRIM.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
300 participants in 3 patient groups
Loading...
Central trial contact
Gilles THURET, MD PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal